The University of Michigan (U-M) Comprehensive Cancer Center has appointed four new leaders to oversee the direction and operation of its research enterprise.
- Pavan Reddy, MD, Deputy Director
- Alnawaz Rehemtulla, PhD, Associate Director for Shared Resources
- Anne Schott, MD, Associate Director for Clinical Research
- Stephen J. Weiss, MD, Associate Director for Basic Science Research
Pavan Reddy, MD
As Deputy Director, Dr. Reddy, Professor and Division Chief of Hematology/Oncology at U-M, will have a key role in the Center’s overall research direction and strategy. He is a leading scientist in understanding the biology and finding ways to prevent or treat graft-vs-host disease.
Alnawaz Rehemtulla, PhD
Dr. Rehemtulla is the Ruth Tuttle Freeman Professor of Radiation Oncology and Professor of Radiology at U-M. He will be charged with adding new services and refinements to the Cancer Center’s shared resources, designed to support and enhance the capabilities of cancer researchers.
Anne Schott, MD
Dr. Schott, Professor of Hematology/Oncology at U-M, will work with clinical researchers to set a strategy for achieving even greater impact in harnessing discoveries to make advances in clinical research. Dr. Schott treats patients with breast cancer and is an active clinical trialist.
Stephen J. Weiss, MD
Dr. Weiss is the E. Gifford and Love Barnett Upjohn Professor of Medicine and Oncology and Research Professor in the U-M Life Sciences Institute. He will oversee the Cancer Center’s four basic science research programs, which focus on the areas of cancer biology, genetics, developmental therapeutics, and immunology. ■
Pavan Reddy, MD
Alnawaz Rehemtulla, PhD
Anne Schott, MD
Stephen J. Weiss, MD
